Page last updated: 2024-10-25

ciprofloxacin and Vaginosis, Bacterial

ciprofloxacin has been researched along with Vaginosis, Bacterial in 6 studies

Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.

Vaginosis, Bacterial: Polymicrobial, nonspecific vaginitis associated with positive cultures of Gardnerella vaginalis and other anaerobic organisms and a decrease in lactobacilli. It remains unclear whether the initial pathogenic event is caused by the growth of anaerobes or a primary decrease in lactobacilli.

Research Excerpts

ExcerptRelevanceReference
"The prevalence of genital mycoplasma infections is very high in women with bacterial vaginosis."1.72Determination of the prevalence of Mycoplasma hominis and Ureaplasma species in Bacterial vaginosis patients in association with antibiotic resistance profile in Franceville, Gabon. ( Lendamba, RW; Mbeang Nguema, PP; Mombo, LE; Onanga, R, 2022)
"Bacterial vaginosis was present in 32% of the women screened, Chlamydia trachomatis was identified in 8%, none tested positive for Neisseria gonorrhoeae."1.32Should we offer antibiotic prophylaxis post sexual assault? ( Forster, GE; Gibb, AM; McManus, T, 2003)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's2 (33.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Lendamba, RW1
Mbeang Nguema, PP1
Onanga, R1
Mombo, LE1
Wang, J1
Li, B1
Li, Y1
Dou, J1
Hao, Q1
Tian, Y1
Wang, H1
Zhou, C1
Swidsinski, A1
Loening-Baucke, V1
Schulz, S1
Manowsky, J1
Verstraelen, H1
Swidsinski, S1
Gibb, AM1
McManus, T1
Forster, GE1
Millán Rodríguez, F1
Rousaud Barón, F1
Rousaud Barón, A1
Fredricsson, B1
Englund, K1
Nord, CE1
Weintraub, L1

Other Studies

6 other studies available for ciprofloxacin and Vaginosis, Bacterial

ArticleYear
Determination of the prevalence of Mycoplasma hominis and Ureaplasma species in Bacterial vaginosis patients in association with antibiotic resistance profile in Franceville, Gabon.
    Microbial pathogenesis, 2022, Volume: 166

    Topics: Anti-Bacterial Agents; Azithromycin; Child; Ciprofloxacin; Coinfection; Drug Resistance, Microbial;

2022
BF-30 effectively inhibits ciprofloxacin-resistant bacteria in vitro and in a rat model of vaginosis.
    Archives of pharmacal research, 2014, Volume: 37, Issue:7

    Topics: Animals; Cathelicidins; Ciprofloxacin; Disease Models, Animal; Drug Resistance, Bacterial; Escherich

2014
Functional anatomy of the colonic bioreactor: Impact of antibiotics and Saccharomyces boulardii on bacterial composition in human fecal cylinders.
    Systematic and applied microbiology, 2016, Volume: 39, Issue:1

    Topics: Anti-Bacterial Agents; Antiprotozoal Agents; Biomass; Bioreactors; Ciprofloxacin; Clostridioides dif

2016
Should we offer antibiotic prophylaxis post sexual assault?
    International journal of STD & AIDS, 2003, Volume: 14, Issue:2

    Topics: Adolescent; Adult; Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Chlamydia t

2003
[Pilot study of coadjuvant treatment of recurrent cystitis in women by means of AM3 (Immnoferon)].
    Actas urologicas espanolas, 2003, Volume: 27, Issue:3

    Topics: Adjuvants, Immunologic; Amoxicillin; Calcium Phosphates; Ciprofloxacin; Clavulanic Acid; Cystitis; D

2003
Could bacterial vaginosis be due to the competitive suppression of lactobacilli by aerobic microorganisms?
    Gynecologic and obstetric investigation, 1992, Volume: 33, Issue:2

    Topics: Adult; Bacteria, Aerobic; Ciprofloxacin; Female; Humans; Lactobacillus; Middle Aged; Vaginosis, Bact

1992